Skip to content
Menu

Reported Friday, Lisata Therapeutics To Be Taken Private By Kuva Labs In A Deal Offering Stockholders $5.00 Per Share Plus A $1.00 Contingent Value Right Per Share

Benzinga Newsdesk 8 months ago

M&ANews

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cash payment of $1.00 per shareBoard of directors unanimously approved the

  • Each Lisata stockholder to receive $5.00 per share in cash payable at closing plus one contingent value right for a potential additional cash payment of $1.00 per share
  • Board of directors unanimously approved the transaction and recommends that stockholders tender their shares
  • Transaction expected to close in the second quarter of 2026

Read at benzinga.com